Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423229PMC

Publication Analysis

Top Keywords

trends iran
4
iran pharmaceutical
4
pharmaceutical market
4
trends
1
pharmaceutical
1
market
1

Similar Publications

Introduction: Mental disorders, such as anxiety and depression, significantly impacted global populations in 2019 and 2020, with COVID-19 causing a surge in prevalence. They affect 13.4% of the people worldwide, and 21% of Iranians have experienced them.

View Article and Find Full Text PDF

Introduction: Cutaneous Leishmaniasis (CL) is a zoonosis infection which is endemic in more than 100 countries in Asia, Africa, Europe and America. It was estimated that nearly 20 thousand of new cases are reported in Iran annually. This study aimed to investigate the impact of floods on the incidence of leishmaniasis in Golestan province (northeast of Iran) over nine years, from 2015 to 2023.

View Article and Find Full Text PDF

Background: The global burden of metabolic diseases is increasing, but estimates of their impact on primary liver cancer are uncertain. We aimed to assess the global burden of primary liver cancer attributable to metabolic risk factors, including high body mass index (BMI) and high fasting plasma glucose (FPG) levels, between 1990 and 2021.

Methods: The total number and age-standardized rates of deaths and disability-adjusted life years (DALYs) from primary liver cancer attributable to each metabolic risk factor were extracted from the Global Burden of Disease Study 1990-2021.

View Article and Find Full Text PDF

Background: Malnutrition, wasting, and obesity among children under 6 years old pose a serious global health concern, increasing the risk of various infectious and non-infectious diseases. Therefore, regular monitoring of these conditions is crucial. This study aimed to evaluate the prevalence of malnutrition in children under 6 years of age from 2018 to 2023.

View Article and Find Full Text PDF

Effect of empagliflozin on weight in patients with prediabetes and diabetes.

Sci Rep

January 2025

Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

The impact of blood glucose-lowering medications on weight has always been a topic of interest in the treatment of diabetic patients. This study investigates the effect of empagliflozin on weight in patients with prediabetes and type 2 diabetes. This quasi-experimental study was performed on patients with prediabetes or type 2 diabetes with an HbA1c level up to 1% higher than the treatment target, and not using other blood glucose-lowering medications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!